1658Tip the STAMPEDE2 177Lutetium-Psma-617 (177Lu-Psma-617) Trial: A Phase III, Randomised, Open-Label Trial in Patients with Metastatic Prostate Cancer (mpc) Starting Androgen Deprivation Therapy (ADT)

M. Padden-Modi,H. Abdel-Aty, C. Jones,L.C. Brown, P. Dutey-Magni, Y. Yogeswaran, A. Horsey,C.L. Amos, I. Murray, N. Hujairi,N. Tunariu,R. Millman,W. Cross, V. Kasivisvanathan,M.K. Parmar,N. Clarke,S. Gillessen,G. Attard,C. Parker,N.D. James

Annals of Oncology（2024）

Cited 0|Views2

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined